nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—NGF-independant TRKA activation—NTRK2—Alzheimer's disease	0.0226	0.136	CbGpPWpGaD
Regadenoson—ADORA2A—Activation of TRKA receptors—NTRK2—Alzheimer's disease	0.0195	0.118	CbGpPWpGaD
Regadenoson—ADORA2A—Activation of TRKA receptors—NGF—Alzheimer's disease	0.0129	0.0779	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—PVRL2—Alzheimer's disease	0.00764	0.0461	CbGpPWpGaD
Regadenoson—Adenosine monophosphate—CREB1—Alzheimer's disease	0.00711	0.508	CrCbGaD
Regadenoson—ADORA2A—forebrain—Alzheimer's disease	0.00595	0.256	CbGeAlD
Regadenoson—ADORA2A—Monoamine Transport—ACHE—Alzheimer's disease	0.00572	0.0345	CbGpPWpGaD
Regadenoson—ADORA2A—telencephalon—Alzheimer's disease	0.00547	0.235	CbGeAlD
Regadenoson—Vasodilation—Donepezil—Alzheimer's disease	0.00545	0.00684	CcSEcCtD
Regadenoson—Vasodilation procedure—Donepezil—Alzheimer's disease	0.00545	0.00684	CcSEcCtD
Regadenoson—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00529	0.00664	CcSEcCtD
Regadenoson—ADORA2A—Monoamine Transport—SLC6A4—Alzheimer's disease	0.00526	0.0317	CbGpPWpGaD
Regadenoson—Pallor—Memantine—Alzheimer's disease	0.00525	0.00658	CcSEcCtD
Regadenoson—Extrasystoles—Memantine—Alzheimer's disease	0.00517	0.00649	CcSEcCtD
Regadenoson—Pallor—Rivastigmine—Alzheimer's disease	0.00513	0.00644	CcSEcCtD
Regadenoson—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00506	0.00635	CcSEcCtD
Regadenoson—Atrioventricular block—Donepezil—Alzheimer's disease	0.00494	0.0062	CcSEcCtD
Regadenoson—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00473	0.00594	CcSEcCtD
Regadenoson—Renal impairment—Galantamine—Alzheimer's disease	0.00471	0.00592	CcSEcCtD
Regadenoson—Wheezing—Donepezil—Alzheimer's disease	0.00465	0.00584	CcSEcCtD
Regadenoson—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00458	0.00575	CcSEcCtD
Regadenoson—Pain in extremity—Galantamine—Alzheimer's disease	0.00449	0.00563	CcSEcCtD
Regadenoson—Atrioventricular block—Memantine—Alzheimer's disease	0.00448	0.00563	CcSEcCtD
Regadenoson—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00439	0.0055	CcSEcCtD
Regadenoson—Depressed level of consciousness—Memantine—Alzheimer's disease	0.0042	0.00527	CcSEcCtD
Regadenoson—Adenosine triphosphate—ABCA1—Alzheimer's disease	0.00397	0.284	CrCbGaD
Regadenoson—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00372	0.00467	CcSEcCtD
Regadenoson—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00367	0.0046	CcSEcCtD
Regadenoson—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00355	0.00445	CcSEcCtD
Regadenoson—Eye pain—Memantine—Alzheimer's disease	0.0035	0.00439	CcSEcCtD
Regadenoson—Eye pain—Rivastigmine—Alzheimer's disease	0.00342	0.00429	CcSEcCtD
Regadenoson—Renal failure—Galantamine—Alzheimer's disease	0.0034	0.00427	CcSEcCtD
Regadenoson—Atrial fibrillation—Memantine—Alzheimer's disease	0.00333	0.00418	CcSEcCtD
Regadenoson—Renal impairment—Memantine—Alzheimer's disease	0.00332	0.00416	CcSEcCtD
Regadenoson—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00326	0.00409	CcSEcCtD
Regadenoson—Renal impairment—Rivastigmine—Alzheimer's disease	0.00325	0.00407	CcSEcCtD
Regadenoson—ADORA2A—nervous system—Alzheimer's disease	0.00323	0.139	CbGeAlD
Regadenoson—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00322	0.00404	CcSEcCtD
Regadenoson—Bradycardia—Galantamine—Alzheimer's disease	0.00316	0.00397	CcSEcCtD
Regadenoson—Pain in extremity—Memantine—Alzheimer's disease	0.00316	0.00396	CcSEcCtD
Regadenoson—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00315	0.00396	CcSEcCtD
Regadenoson—ADORA2A—central nervous system—Alzheimer's disease	0.00311	0.134	CbGeAlD
Regadenoson—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00309	0.00388	CcSEcCtD
Regadenoson—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00305	0.00383	CcSEcCtD
Regadenoson—ADORA2A—G alpha (s) signalling events—HTR6—Alzheimer's disease	0.00304	0.0183	CbGpPWpGaD
Regadenoson—ADORA2A—cerebellum—Alzheimer's disease	0.00304	0.131	CbGeAlD
Regadenoson—Abdominal distension—Donepezil—Alzheimer's disease	0.00303	0.0038	CcSEcCtD
Regadenoson—Asthma—Donepezil—Alzheimer's disease	0.00301	0.00377	CcSEcCtD
Regadenoson—Cardiac arrest—Memantine—Alzheimer's disease	0.003	0.00377	CcSEcCtD
Regadenoson—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00294	0.00369	CcSEcCtD
Regadenoson—Angina pectoris—Donepezil—Alzheimer's disease	0.00293	0.00367	CcSEcCtD
Regadenoson—Adenosine triphosphate—AKT1—Alzheimer's disease	0.00292	0.208	CrCbGaD
Regadenoson—Eye disorder—Galantamine—Alzheimer's disease	0.0029	0.00364	CcSEcCtD
Regadenoson—Tinnitus—Galantamine—Alzheimer's disease	0.00289	0.00363	CcSEcCtD
Regadenoson—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00288	0.00362	CcSEcCtD
Regadenoson—Flushing—Galantamine—Alzheimer's disease	0.00288	0.00362	CcSEcCtD
Regadenoson—Cardiac disorder—Galantamine—Alzheimer's disease	0.00288	0.00362	CcSEcCtD
Regadenoson—Angiopathy—Galantamine—Alzheimer's disease	0.00282	0.00353	CcSEcCtD
Regadenoson—Immune system disorder—Galantamine—Alzheimer's disease	0.0028	0.00352	CcSEcCtD
Regadenoson—Asthma—Memantine—Alzheimer's disease	0.00273	0.00342	CcSEcCtD
Regadenoson—Mental disorder—Galantamine—Alzheimer's disease	0.00272	0.00341	CcSEcCtD
Regadenoson—Bronchospasm—Memantine—Alzheimer's disease	0.00268	0.00337	CcSEcCtD
Regadenoson—Angina pectoris—Memantine—Alzheimer's disease	0.00266	0.00334	CcSEcCtD
Regadenoson—Dysgeusia—Galantamine—Alzheimer's disease	0.00265	0.00332	CcSEcCtD
Regadenoson—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00264	0.00331	CcSEcCtD
Regadenoson—Renal failure—Donepezil—Alzheimer's disease	0.00263	0.00331	CcSEcCtD
Regadenoson—Myocardial infarction—Donepezil—Alzheimer's disease	0.00263	0.0033	CcSEcCtD
Regadenoson—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00263	0.0033	CcSEcCtD
Regadenoson—Angina pectoris—Rivastigmine—Alzheimer's disease	0.0026	0.00326	CcSEcCtD
Regadenoson—Vision blurred—Galantamine—Alzheimer's disease	0.00255	0.0032	CcSEcCtD
Regadenoson—Tremor—Galantamine—Alzheimer's disease	0.00253	0.00318	CcSEcCtD
Regadenoson—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00251	0.00315	CcSEcCtD
Regadenoson—ADORA2A—brain—Alzheimer's disease	0.00247	0.106	CbGeAlD
Regadenoson—Bradycardia—Donepezil—Alzheimer's disease	0.00245	0.00307	CcSEcCtD
Regadenoson—Malaise—Galantamine—Alzheimer's disease	0.00244	0.00306	CcSEcCtD
Regadenoson—Syncope—Galantamine—Alzheimer's disease	0.00242	0.00304	CcSEcCtD
Regadenoson—Acute coronary syndrome—Memantine—Alzheimer's disease	0.0024	0.00301	CcSEcCtD
Regadenoson—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00239	0.003	CcSEcCtD
Regadenoson—Renal failure—Memantine—Alzheimer's disease	0.00239	0.003	CcSEcCtD
Regadenoson—Palpitations—Galantamine—Alzheimer's disease	0.00239	0.003	CcSEcCtD
Regadenoson—Myocardial infarction—Memantine—Alzheimer's disease	0.00239	0.00299	CcSEcCtD
Regadenoson—Loss of consciousness—Galantamine—Alzheimer's disease	0.00237	0.00298	CcSEcCtD
Regadenoson—Cough—Galantamine—Alzheimer's disease	0.00236	0.00296	CcSEcCtD
Regadenoson—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00235	0.00294	CcSEcCtD
Regadenoson—Convulsion—Galantamine—Alzheimer's disease	0.00234	0.00294	CcSEcCtD
Regadenoson—Renal failure—Rivastigmine—Alzheimer's disease	0.00234	0.00294	CcSEcCtD
Regadenoson—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00233	0.00293	CcSEcCtD
Regadenoson—Hypertension—Galantamine—Alzheimer's disease	0.00233	0.00293	CcSEcCtD
Regadenoson—Myalgia—Galantamine—Alzheimer's disease	0.0023	0.00289	CcSEcCtD
Regadenoson—Arthralgia—Galantamine—Alzheimer's disease	0.0023	0.00289	CcSEcCtD
Regadenoson—Chest pain—Galantamine—Alzheimer's disease	0.0023	0.00289	CcSEcCtD
Regadenoson—Anxiety—Galantamine—Alzheimer's disease	0.00229	0.00288	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00228	0.00287	CcSEcCtD
Regadenoson—Discomfort—Galantamine—Alzheimer's disease	0.00227	0.00285	CcSEcCtD
Regadenoson—Tinnitus—Donepezil—Alzheimer's disease	0.00224	0.00281	CcSEcCtD
Regadenoson—Bradycardia—Memantine—Alzheimer's disease	0.00222	0.00279	CcSEcCtD
Regadenoson—Bradycardia—Rivastigmine—Alzheimer's disease	0.00218	0.00273	CcSEcCtD
Regadenoson—Hypoaesthesia—Memantine—Alzheimer's disease	0.00217	0.00273	CcSEcCtD
Regadenoson—Shock—Galantamine—Alzheimer's disease	0.00217	0.00272	CcSEcCtD
Regadenoson—Nervous system disorder—Galantamine—Alzheimer's disease	0.00216	0.00271	CcSEcCtD
Regadenoson—Tachycardia—Galantamine—Alzheimer's disease	0.00215	0.0027	CcSEcCtD
Regadenoson—Connective tissue disorder—Memantine—Alzheimer's disease	0.00215	0.00269	CcSEcCtD
Regadenoson—Skin disorder—Galantamine—Alzheimer's disease	0.00214	0.00269	CcSEcCtD
Regadenoson—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00213	0.00268	CcSEcCtD
Regadenoson—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00213	0.00267	CcSEcCtD
Regadenoson—Mental disorder—Donepezil—Alzheimer's disease	0.00211	0.00264	CcSEcCtD
Regadenoson—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.0021	0.00263	CcSEcCtD
Regadenoson—Erythema—Donepezil—Alzheimer's disease	0.00209	0.00263	CcSEcCtD
Regadenoson—Hypotension—Galantamine—Alzheimer's disease	0.00206	0.00259	CcSEcCtD
Regadenoson—Dysgeusia—Donepezil—Alzheimer's disease	0.00205	0.00257	CcSEcCtD
Regadenoson—Eye disorder—Memantine—Alzheimer's disease	0.00204	0.00256	CcSEcCtD
Regadenoson—Tinnitus—Memantine—Alzheimer's disease	0.00204	0.00256	CcSEcCtD
Regadenoson—Cardiac disorder—Memantine—Alzheimer's disease	0.00203	0.00254	CcSEcCtD
Regadenoson—Flushing—Memantine—Alzheimer's disease	0.00203	0.00254	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00201	0.00252	CcSEcCtD
Regadenoson—Eye disorder—Rivastigmine—Alzheimer's disease	0.002	0.00251	CcSEcCtD
Regadenoson—Insomnia—Galantamine—Alzheimer's disease	0.00199	0.0025	CcSEcCtD
Regadenoson—Tinnitus—Rivastigmine—Alzheimer's disease	0.00199	0.0025	CcSEcCtD
Regadenoson—Flushing—Rivastigmine—Alzheimer's disease	0.00198	0.00249	CcSEcCtD
Regadenoson—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00198	0.00249	CcSEcCtD
Regadenoson—Angiopathy—Memantine—Alzheimer's disease	0.00198	0.00249	CcSEcCtD
Regadenoson—Paraesthesia—Galantamine—Alzheimer's disease	0.00198	0.00248	CcSEcCtD
Regadenoson—Vision blurred—Donepezil—Alzheimer's disease	0.00197	0.00248	CcSEcCtD
Regadenoson—Immune system disorder—Memantine—Alzheimer's disease	0.00197	0.00248	CcSEcCtD
Regadenoson—ADORA2A—G alpha (s) signalling events—IAPP—Alzheimer's disease	0.00197	0.0119	CbGpPWpGaD
Regadenoson—Mediastinal disorder—Memantine—Alzheimer's disease	0.00197	0.00247	CcSEcCtD
Regadenoson—Tremor—Donepezil—Alzheimer's disease	0.00196	0.00246	CcSEcCtD
Regadenoson—Somnolence—Galantamine—Alzheimer's disease	0.00196	0.00246	CcSEcCtD
Regadenoson—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00194	0.00244	CcSEcCtD
Regadenoson—Angiopathy—Rivastigmine—Alzheimer's disease	0.00194	0.00243	CcSEcCtD
Regadenoson—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00193	0.00242	CcSEcCtD
Regadenoson—Mental disorder—Memantine—Alzheimer's disease	0.00191	0.0024	CcSEcCtD
Regadenoson—ADORA2A—G alpha (s) signalling events—CRH—Alzheimer's disease	0.00191	0.0115	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—IL1B—Alzheimer's disease	0.00191	0.0115	CbGpPWpGaD
Regadenoson—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.0019	0.00239	CcSEcCtD
Regadenoson—Malaise—Donepezil—Alzheimer's disease	0.00189	0.00237	CcSEcCtD
Regadenoson—Syncope—Donepezil—Alzheimer's disease	0.00188	0.00236	CcSEcCtD
Regadenoson—Mental disorder—Rivastigmine—Alzheimer's disease	0.00187	0.00235	CcSEcCtD
Regadenoson—Dysgeusia—Memantine—Alzheimer's disease	0.00186	0.00234	CcSEcCtD
Regadenoson—Erythema—Rivastigmine—Alzheimer's disease	0.00186	0.00233	CcSEcCtD
Regadenoson—Loss of consciousness—Donepezil—Alzheimer's disease	0.00184	0.00231	CcSEcCtD
Regadenoson—Cough—Donepezil—Alzheimer's disease	0.00183	0.00229	CcSEcCtD
Regadenoson—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00182	0.00229	CcSEcCtD
Regadenoson—Feeling abnormal—Galantamine—Alzheimer's disease	0.00182	0.00228	CcSEcCtD
Regadenoson—Convulsion—Donepezil—Alzheimer's disease	0.00181	0.00228	CcSEcCtD
Regadenoson—ADORA2A—G alpha (s) signalling events—NPS—Alzheimer's disease	0.00181	0.0109	CbGpPWpGaD
Regadenoson—Hypertension—Donepezil—Alzheimer's disease	0.00181	0.00227	CcSEcCtD
Regadenoson—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.0018	0.00226	CcSEcCtD
Regadenoson—Vision blurred—Memantine—Alzheimer's disease	0.00179	0.00225	CcSEcCtD
Regadenoson—Arthralgia—Donepezil—Alzheimer's disease	0.00178	0.00224	CcSEcCtD
Regadenoson—Myalgia—Donepezil—Alzheimer's disease	0.00178	0.00224	CcSEcCtD
Regadenoson—Chest pain—Donepezil—Alzheimer's disease	0.00178	0.00224	CcSEcCtD
Regadenoson—Tremor—Memantine—Alzheimer's disease	0.00178	0.00224	CcSEcCtD
Regadenoson—Anxiety—Donepezil—Alzheimer's disease	0.00178	0.00223	CcSEcCtD
Regadenoson—Ill-defined disorder—Memantine—Alzheimer's disease	0.00176	0.00221	CcSEcCtD
Regadenoson—Discomfort—Donepezil—Alzheimer's disease	0.00176	0.00221	CcSEcCtD
Regadenoson—Vision blurred—Rivastigmine—Alzheimer's disease	0.00175	0.0022	CcSEcCtD
Regadenoson—Abdominal pain—Galantamine—Alzheimer's disease	0.00174	0.00219	CcSEcCtD
Regadenoson—Tremor—Rivastigmine—Alzheimer's disease	0.00174	0.00219	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00174	0.0105	CbGpPWpGaD
Regadenoson—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00173	0.00217	CcSEcCtD
Regadenoson—Malaise—Memantine—Alzheimer's disease	0.00171	0.00215	CcSEcCtD
Regadenoson—Syncope—Memantine—Alzheimer's disease	0.00171	0.00214	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.00169	0.0102	CbGpPWpGaD
Regadenoson—Shock—Donepezil—Alzheimer's disease	0.00168	0.00211	CcSEcCtD
Regadenoson—Palpitations—Memantine—Alzheimer's disease	0.00168	0.00211	CcSEcCtD
Regadenoson—Malaise—Rivastigmine—Alzheimer's disease	0.00168	0.0021	CcSEcCtD
Regadenoson—Nervous system disorder—Donepezil—Alzheimer's disease	0.00168	0.0021	CcSEcCtD
Regadenoson—Loss of consciousness—Memantine—Alzheimer's disease	0.00167	0.0021	CcSEcCtD
Regadenoson—Syncope—Rivastigmine—Alzheimer's disease	0.00167	0.00209	CcSEcCtD
Regadenoson—Cough—Memantine—Alzheimer's disease	0.00166	0.00208	CcSEcCtD
Regadenoson—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00165	0.00207	CcSEcCtD
Regadenoson—Convulsion—Memantine—Alzheimer's disease	0.00165	0.00207	CcSEcCtD
Regadenoson—Palpitations—Rivastigmine—Alzheimer's disease	0.00164	0.00206	CcSEcCtD
Regadenoson—Hypertension—Memantine—Alzheimer's disease	0.00164	0.00206	CcSEcCtD
Regadenoson—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00163	0.00205	CcSEcCtD
Regadenoson—Hypersensitivity—Galantamine—Alzheimer's disease	0.00162	0.00204	CcSEcCtD
Regadenoson—Cough—Rivastigmine—Alzheimer's disease	0.00162	0.00204	CcSEcCtD
Regadenoson—Myalgia—Memantine—Alzheimer's disease	0.00162	0.00203	CcSEcCtD
Regadenoson—Chest pain—Memantine—Alzheimer's disease	0.00162	0.00203	CcSEcCtD
Regadenoson—Arthralgia—Memantine—Alzheimer's disease	0.00162	0.00203	CcSEcCtD
Regadenoson—Anxiety—Memantine—Alzheimer's disease	0.00161	0.00202	CcSEcCtD
Regadenoson—Convulsion—Rivastigmine—Alzheimer's disease	0.00161	0.00202	CcSEcCtD
Regadenoson—Hypertension—Rivastigmine—Alzheimer's disease	0.00161	0.00202	CcSEcCtD
Regadenoson—Discomfort—Memantine—Alzheimer's disease	0.0016	0.00201	CcSEcCtD
Regadenoson—Hypotension—Donepezil—Alzheimer's disease	0.0016	0.002	CcSEcCtD
Regadenoson—Arthralgia—Rivastigmine—Alzheimer's disease	0.00158	0.00199	CcSEcCtD
Regadenoson—Chest pain—Rivastigmine—Alzheimer's disease	0.00158	0.00199	CcSEcCtD
Regadenoson—Myalgia—Rivastigmine—Alzheimer's disease	0.00158	0.00199	CcSEcCtD
Regadenoson—Asthenia—Galantamine—Alzheimer's disease	0.00158	0.00199	CcSEcCtD
Regadenoson—Anxiety—Rivastigmine—Alzheimer's disease	0.00158	0.00198	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00157	0.00197	CcSEcCtD
Regadenoson—Discomfort—Rivastigmine—Alzheimer's disease	0.00156	0.00196	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00156	0.00195	CcSEcCtD
Regadenoson—Insomnia—Donepezil—Alzheimer's disease	0.00155	0.00194	CcSEcCtD
Regadenoson—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—Alzheimer's disease	0.00154	0.00929	CbGpPWpGaD
Regadenoson—Paraesthesia—Donepezil—Alzheimer's disease	0.00153	0.00193	CcSEcCtD
Regadenoson—Shock—Memantine—Alzheimer's disease	0.00153	0.00192	CcSEcCtD
Regadenoson—Dyspnoea—Donepezil—Alzheimer's disease	0.00152	0.00191	CcSEcCtD
Regadenoson—Nervous system disorder—Memantine—Alzheimer's disease	0.00152	0.00191	CcSEcCtD
Regadenoson—Somnolence—Donepezil—Alzheimer's disease	0.00152	0.00191	CcSEcCtD
Regadenoson—Tachycardia—Memantine—Alzheimer's disease	0.00151	0.0019	CcSEcCtD
Regadenoson—Diarrhoea—Galantamine—Alzheimer's disease	0.00151	0.00189	CcSEcCtD
Regadenoson—Skin disorder—Memantine—Alzheimer's disease	0.00151	0.00189	CcSEcCtD
Regadenoson—Hyperhidrosis—Memantine—Alzheimer's disease	0.0015	0.00188	CcSEcCtD
Regadenoson—Shock—Rivastigmine—Alzheimer's disease	0.00149	0.00187	CcSEcCtD
Regadenoson—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00149	0.00187	CcSEcCtD
Regadenoson—Tachycardia—Rivastigmine—Alzheimer's disease	0.00148	0.00186	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00148	0.00185	CcSEcCtD
Regadenoson—Skin disorder—Rivastigmine—Alzheimer's disease	0.00147	0.00185	CcSEcCtD
Regadenoson—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00147	0.00184	CcSEcCtD
Regadenoson—Pain—Donepezil—Alzheimer's disease	0.00146	0.00183	CcSEcCtD
Regadenoson—Dizziness—Galantamine—Alzheimer's disease	0.00146	0.00183	CcSEcCtD
Regadenoson—Hypotension—Memantine—Alzheimer's disease	0.00145	0.00182	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00145	0.00874	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.00143	0.00863	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—CST3—Alzheimer's disease	0.00143	0.00863	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—CCR5—Alzheimer's disease	0.00143	0.00861	CbGpPWpGaD
Regadenoson—Hypotension—Rivastigmine—Alzheimer's disease	0.00142	0.00178	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—PSENEN—Alzheimer's disease	0.00141	0.00853	CbGpPWpGaD
Regadenoson—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00141	0.00177	CcSEcCtD
Regadenoson—Feeling abnormal—Donepezil—Alzheimer's disease	0.00141	0.00177	CcSEcCtD
Regadenoson—Insomnia—Memantine—Alzheimer's disease	0.0014	0.00176	CcSEcCtD
Regadenoson—Vomiting—Galantamine—Alzheimer's disease	0.0014	0.00176	CcSEcCtD
Regadenoson—ADORA2A—GPCRs, Other—HTR2A—Alzheimer's disease	0.0014	0.00843	CbGpPWpGaD
Regadenoson—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.0014	0.00175	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—APH1A—Alzheimer's disease	0.00139	0.00841	CbGpPWpGaD
Regadenoson—Paraesthesia—Memantine—Alzheimer's disease	0.00139	0.00175	CcSEcCtD
Regadenoson—Rash—Galantamine—Alzheimer's disease	0.00139	0.00174	CcSEcCtD
Regadenoson—Dermatitis—Galantamine—Alzheimer's disease	0.00139	0.00174	CcSEcCtD
Regadenoson—ADORA2A—Monoamine Transport—TNF—Alzheimer's disease	0.00139	0.00836	CbGpPWpGaD
Regadenoson—Dyspnoea—Memantine—Alzheimer's disease	0.00138	0.00174	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00138	0.00174	CcSEcCtD
Regadenoson—Headache—Galantamine—Alzheimer's disease	0.00138	0.00173	CcSEcCtD
Regadenoson—Somnolence—Memantine—Alzheimer's disease	0.00138	0.00173	CcSEcCtD
Regadenoson—Insomnia—Rivastigmine—Alzheimer's disease	0.00137	0.00172	CcSEcCtD
Regadenoson—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00136	0.00171	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—NCSTN—Alzheimer's disease	0.00136	0.00819	CbGpPWpGaD
Regadenoson—Urticaria—Donepezil—Alzheimer's disease	0.00136	0.0017	CcSEcCtD
Regadenoson—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00135	0.0017	CcSEcCtD
Regadenoson—Abdominal pain—Donepezil—Alzheimer's disease	0.00135	0.0017	CcSEcCtD
Regadenoson—Somnolence—Rivastigmine—Alzheimer's disease	0.00135	0.00169	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00134	0.00168	CcSEcCtD
Regadenoson—Pain—Memantine—Alzheimer's disease	0.00133	0.00167	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—PYY—Alzheimer's disease	0.00132	0.00797	CbGpPWpGaD
Regadenoson—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00131	0.00164	CcSEcCtD
Regadenoson—Nausea—Galantamine—Alzheimer's disease	0.00131	0.00164	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—CRH—Alzheimer's disease	0.0013	0.00784	CbGpPWpGaD
Regadenoson—Pain—Rivastigmine—Alzheimer's disease	0.0013	0.00163	CcSEcCtD
Regadenoson—Feeling abnormal—Memantine—Alzheimer's disease	0.00128	0.0016	CcSEcCtD
Regadenoson—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00127	0.00159	CcSEcCtD
Regadenoson—Hypersensitivity—Donepezil—Alzheimer's disease	0.00126	0.00158	CcSEcCtD
Regadenoson—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00125	0.00157	CcSEcCtD
Regadenoson—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00124	0.00156	CcSEcCtD
Regadenoson—Urticaria—Memantine—Alzheimer's disease	0.00123	0.00155	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—NPS—Alzheimer's disease	0.00123	0.00743	CbGpPWpGaD
Regadenoson—Abdominal pain—Memantine—Alzheimer's disease	0.00123	0.00154	CcSEcCtD
Regadenoson—Asthenia—Donepezil—Alzheimer's disease	0.00123	0.00154	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—SLC6A4—Alzheimer's disease	0.00121	0.00729	CbGpPWpGaD
Regadenoson—Urticaria—Rivastigmine—Alzheimer's disease	0.00121	0.00151	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.0012	0.00726	CbGpPWpGaD
Regadenoson—Abdominal pain—Rivastigmine—Alzheimer's disease	0.0012	0.00151	CcSEcCtD
Regadenoson—Diarrhoea—Donepezil—Alzheimer's disease	0.00117	0.00147	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—Alzheimer's disease	0.00115	0.00695	CbGpPWpGaD
Regadenoson—Hypersensitivity—Memantine—Alzheimer's disease	0.00114	0.00143	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—GSK3A—Alzheimer's disease	0.00114	0.00689	CbGpPWpGaD
Regadenoson—Dizziness—Donepezil—Alzheimer's disease	0.00113	0.00142	CcSEcCtD
Regadenoson—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00112	0.0014	CcSEcCtD
Regadenoson—Asthenia—Memantine—Alzheimer's disease	0.00111	0.0014	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—PSEN2—Alzheimer's disease	0.0011	0.00666	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR6—Alzheimer's disease	0.0011	0.00665	CbGpPWpGaD
Regadenoson—Asthenia—Rivastigmine—Alzheimer's disease	0.00109	0.00137	CcSEcCtD
Regadenoson—Vomiting—Donepezil—Alzheimer's disease	0.00109	0.00136	CcSEcCtD
Regadenoson—Rash—Donepezil—Alzheimer's disease	0.00108	0.00135	CcSEcCtD
Regadenoson—Dermatitis—Donepezil—Alzheimer's disease	0.00108	0.00135	CcSEcCtD
Regadenoson—Headache—Donepezil—Alzheimer's disease	0.00107	0.00134	CcSEcCtD
Regadenoson—Diarrhoea—Memantine—Alzheimer's disease	0.00106	0.00133	CcSEcCtD
Regadenoson—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00104	0.0013	CcSEcCtD
Regadenoson—Dizziness—Memantine—Alzheimer's disease	0.00103	0.00129	CcSEcCtD
Regadenoson—Nausea—Donepezil—Alzheimer's disease	0.00102	0.00127	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—NGFR—Alzheimer's disease	0.00101	0.00608	CbGpPWpGaD
Regadenoson—Dizziness—Rivastigmine—Alzheimer's disease	0.001	0.00126	CcSEcCtD
Regadenoson—Vomiting—Memantine—Alzheimer's disease	0.000987	0.00124	CcSEcCtD
Regadenoson—Rash—Memantine—Alzheimer's disease	0.000978	0.00123	CcSEcCtD
Regadenoson—Dermatitis—Memantine—Alzheimer's disease	0.000978	0.00123	CcSEcCtD
Regadenoson—Headache—Memantine—Alzheimer's disease	0.000972	0.00122	CcSEcCtD
Regadenoson—Vomiting—Rivastigmine—Alzheimer's disease	0.000965	0.00121	CcSEcCtD
Regadenoson—Rash—Rivastigmine—Alzheimer's disease	0.000957	0.0012	CcSEcCtD
Regadenoson—Dermatitis—Rivastigmine—Alzheimer's disease	0.000956	0.0012	CcSEcCtD
Regadenoson—Headache—Rivastigmine—Alzheimer's disease	0.000951	0.00119	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000946	0.0057	CbGpPWpGaD
Regadenoson—Nausea—Memantine—Alzheimer's disease	0.000922	0.00116	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—GAL—Alzheimer's disease	0.000917	0.00553	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.000903	0.00545	CbGpPWpGaD
Regadenoson—Nausea—Rivastigmine—Alzheimer's disease	0.000902	0.00113	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—NTRK2—Alzheimer's disease	0.000887	0.00535	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—GSK3A—Alzheimer's disease	0.000879	0.0053	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000865	0.00521	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000825	0.00497	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000804	0.00485	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.0008	0.00482	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—MEF2C—Alzheimer's disease	0.000799	0.00482	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—PRKCG—Alzheimer's disease	0.000784	0.00473	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—Alzheimer's disease	0.000764	0.0046	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NGFR—Alzheimer's disease	0.000761	0.00459	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PYY—Alzheimer's disease	0.000747	0.00451	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—NPY—Alzheimer's disease	0.00072	0.00434	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—IAPP—Alzheimer's disease	0.000716	0.00431	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CRH—Alzheimer's disease	0.000695	0.00419	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—LEP—Alzheimer's disease	0.000689	0.00416	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PYY—Alzheimer's disease	0.000679	0.00409	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—CALM1—Alzheimer's disease	0.000678	0.00409	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—NPS—Alzheimer's disease	0.000659	0.00397	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000642	0.00387	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—SST—Alzheimer's disease	0.000628	0.00379	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000624	0.00376	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.00062	0.00374	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—MEF2C—Alzheimer's disease	0.000615	0.00371	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—APP—Alzheimer's disease	0.000612	0.00369	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000607	0.00366	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—PRKCG—Alzheimer's disease	0.000603	0.00364	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—PPARG—Alzheimer's disease	0.0006	0.00362	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000597	0.0036	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—CREB1—Alzheimer's disease	0.000592	0.00357	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CDK5—Alzheimer's disease	0.000588	0.00355	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NGF—Alzheimer's disease	0.000587	0.00354	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—GSK3B—Alzheimer's disease	0.000585	0.00353	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—CREB1—Alzheimer's disease	0.000581	0.0035	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR6—Alzheimer's disease	0.000566	0.00342	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000532	0.00321	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CALM1—Alzheimer's disease	0.000522	0.00315	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00052	0.00314	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GAL—Alzheimer's disease	0.000518	0.00312	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GAL—Alzheimer's disease	0.00047	0.00284	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TTR—Alzheimer's disease	0.000459	0.00277	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000456	0.00275	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—GSK3B—Alzheimer's disease	0.00045	0.00271	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CREB1—Alzheimer's disease	0.000447	0.00269	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000407	0.00245	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000407	0.00245	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCR5—Alzheimer's disease	0.000405	0.00244	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000404	0.00244	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000403	0.00243	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PYY—Alzheimer's disease	0.000401	0.00242	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000396	0.00239	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000393	0.00237	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000372	0.00224	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPY—Alzheimer's disease	0.00037	0.00223	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000367	0.00221	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CRH—Alzheimer's disease	0.000356	0.00215	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—SST—Alzheimer's disease	0.000355	0.00214	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000355	0.00214	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CDK5—Alzheimer's disease	0.000348	0.0021	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—F2—Alzheimer's disease	0.000347	0.00209	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—APP—Alzheimer's disease	0.000346	0.00209	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPS—Alzheimer's disease	0.000338	0.00204	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000336	0.00203	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR6—Alzheimer's disease	0.000335	0.00202	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CASP3—Alzheimer's disease	0.000331	0.00199	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000326	0.00197	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000322	0.00194	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—SST—Alzheimer's disease	0.000322	0.00194	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—APP—Alzheimer's disease	0.000314	0.00189	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL2—Alzheimer's disease	0.00031	0.00187	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—MAPK8—Alzheimer's disease	0.000304	0.00183	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000304	0.00183	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APH1A—Alzheimer's disease	0.0003	0.00181	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000296	0.00179	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000292	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LRP1—Alzheimer's disease	0.000284	0.00172	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—TP53—Alzheimer's disease	0.000281	0.00169	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GFAP—Alzheimer's disease	0.000278	0.00168	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GAL—Alzheimer's disease	0.000278	0.00168	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—Alzheimer's disease	0.000257	0.00155	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Alzheimer's disease	0.000252	0.00152	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—A2M—Alzheimer's disease	0.000245	0.00148	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000241	0.00146	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000237	0.00143	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	0.000233	0.0014	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000229	0.00138	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000224	0.00135	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000219	0.00132	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NPY—Alzheimer's disease	0.000218	0.00132	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IAPP—Alzheimer's disease	0.000217	0.00131	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CRH—Alzheimer's disease	0.000211	0.00127	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000208	0.00125	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000203	0.00123	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NPS—Alzheimer's disease	0.0002	0.0012	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000199	0.0012	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—F2—Alzheimer's disease	0.000196	0.00118	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000196	0.00118	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—IL6—Alzheimer's disease	0.000194	0.00117	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NTRK2—Alzheimer's disease	0.00019	0.00115	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SST—Alzheimer's disease	0.00019	0.00115	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GAB2—Alzheimer's disease	0.00019	0.00115	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CALM1—Alzheimer's disease	0.00019	0.00114	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000189	0.00114	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APP—Alzheimer's disease	0.000186	0.00112	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—AKT1—Alzheimer's disease	0.000179	0.00108	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—F2—Alzheimer's disease	0.000178	0.00107	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000175	0.00106	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGFR—Alzheimer's disease	0.000163	0.000985	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000162	0.000979	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADAM10—Alzheimer's disease	0.00016	0.000962	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000159	0.000958	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—S100B—Alzheimer's disease	0.000151	0.00091	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF2—Alzheimer's disease	0.000144	0.000866	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000139	0.000838	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LPL—Alzheimer's disease	0.000133	0.000803	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000132	0.000796	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCG—Alzheimer's disease	0.00013	0.000781	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGF—Alzheimer's disease	0.000126	0.000761	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR5—Alzheimer's disease	0.000123	0.00074	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2A—Alzheimer's disease	0.00012	0.000724	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CALM1—Alzheimer's disease	0.000112	0.000676	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LEP—Alzheimer's disease	0.000112	0.000673	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOE—Alzheimer's disease	0.000112	0.000673	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CAV1—Alzheimer's disease	0.000111	0.000667	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ESR1—Alzheimer's disease	0.000107	0.000643	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—F2—Alzheimer's disease	0.000105	0.000635	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000103	0.000621	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GSK3B—Alzheimer's disease	9.67e-05	0.000583	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CREB1—Alzheimer's disease	9.59e-05	0.000578	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—INS—Alzheimer's disease	9.54e-05	0.000575	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL2—Alzheimer's disease	9.38e-05	0.000566	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF1—Alzheimer's disease	9.23e-05	0.000556	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOS3—Alzheimer's disease	8.36e-05	0.000504	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	7.17e-05	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CASP3—Alzheimer's disease	7.1e-05	0.000428	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—Alzheimer's disease	7.06e-05	0.000425	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAPK8—Alzheimer's disease	6.53e-05	0.000394	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AKT1—Alzheimer's disease	6.51e-05	0.000392	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VEGFA—Alzheimer's disease	6.03e-05	0.000363	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFB1—Alzheimer's disease	5.53e-05	0.000334	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TP53—Alzheimer's disease	4.55e-05	0.000275	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—Alzheimer's disease	4.17e-05	0.000251	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AKT1—Alzheimer's disease	3.85e-05	0.000232	CbGpPWpGaD
